In patients undergoing transfemoral coronary angiography and percutaneous coronary intervention (PCI), use of a vascular closure device results in reduced rates of complications compared with manual ...
ISAR-CLOSURE: Vascular Closure Devices Noninferior to Manual Compression in Transfemoral Angiography
New data presented Saturday at TCT 2014 show that, in patients undergoing transfemoral coronary angiography, vascular closure devices match manual compression in terms of vascular access site ...
Results from the largest randomized trial available comparing different closure device strategies following transcatheter aortic valve replacement (TAVR) found that a plug-based vascular closure ...
Results from an analysis of a large randomized trial shows ProGlide vascular closure device (VCD) was associated with lower rates of vascular complications, lower rates of acute kidney injury (AKI) ...
In an analysis of the ISAR-CLOSURE trial, use of vascular closure devices was as safe and effective as manual compression for artery closure in women undergoing transfemoral angiography. Researchers ...
June 2, 2010 (Kansas City, Missouri) — A treatment strategy that involves the use of a vascular closure device and bivalirudin (Angiomax, the Medicines Company) reduces the risk of periprocedural ...
Vascular closure devices market is expected to reach $984.6 million from $704.8 million, at a CAGR of 6.9% from 2016-2021.Major drivers include large number of approvals for vascular closure devices, ...
The global vascular closure devices market is expected to reach USD 984.6 million by 2022 from USD 704.8 million in 2017, at a CAGR of 6.9%. The market is segmented on the basis of type, access, ...
Please provide your email address to receive an email when new articles are posted on . The CHOICE-CLOSURE trial was presented by Mohamed Abdel-Wahab, MD, consultant cardiologist and head of the ...
WAYNE, Pa.--(BUSINESS WIRE)--Teleflex Incorporated (NYSE: TFX), a leading global provider of medical technologies for critical care and surgery, has announced that it received premarket approval (PMA) ...
The process of assuring the safety of medical devices is constrained by reliance on voluntary reporting of adverse events. We evaluated a strategy of prospective, active surveillance of a national ...
DUBLIN--(BUSINESS WIRE)--The "Peripheral Vascular Devices Market Report Suite | United States | 2020-2026 | MedSuite" report has been added to ResearchAndMarkets.com's offering. One of the greatest ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results